Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism PAPD5 modulators(terminal nucleotidyltransferase 4B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Redona Therapeutics, Inc.Startup |
Active Organization Redona Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | US | Redona Therapeutics, Inc.Startup | 22 Jun 2024 |
Telomere Syndrome | Preclinical | US | Redona Therapeutics, Inc.Startup | 22 Jun 2024 |